Public Health England have published the second annual ESPAUR (English Surveillance Programme for Antimicrobial Utilisation and Resistance) report, which shows that overall antibiotic resistant infections increased through 2014.
The All Party Parliamentary Group for Life Sciences, for which BIVDA provides secretarial support as part of Life Sciences UK, has published a letter in the Sunday Times supporting funding calls ahead of the Comprehensive Spending Review (CSR).
The Science and Technology Committee (Commons) have today released their first report into the science budget, stating that the UK must increase science funding to keep up with competitors.
The Accelerated Access Review today published its interim findings, ahead of the full report, with more detailed recommendations, due out in April 2016. Sir Hugh Taylor sets out 5 propositions to speed up access to transformative health technology that can change the lives of NHS patients.
The Precision Medicine Catapult, led by John McKinley, today announced the locations of six initial regional centres of excellence as Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford.
Chief Executive of BIVDA, Doris-Ann Williams MBE, has responded to the Jim O'Neill Review on Antimicrobial Resistance, entitled Rapid Diagnostics: Stopping Unnecessary Use of Antibiotics.
Andrew Dunlop, the Scotland Office Minister, attended the Milan Expo to promote Scotland's life sciences sector.
Sir Hugh Taylor, Chair of the Accelerated Access Review, announced today that the review will now report in April 2016.
NHS Business Services Authority announces two year contract extension for the NHS Supply Chain service with DHL.
The contract’s aim is to drive value for the NHS by delivering an increased cash releasing savings target of £300m by October 2018.
The NHS Business Services Authority is pleased to announce that the current NHS Supply Chain service contract has been extended with DHL by two years from 2016 until 2018.
Thousands of cancer patients are missing out on personalised treatments each year in England because they are not being given a test to see if they might benefit from them, according to a new report from Cancer Research UK.
News, Policy & Media
BIVDA Press Releases
Click here to view more of our Parliamentary Newsletters
© 2015 BIVDA Ltd is registered in England, with Company Number 2687137
Registered Office is Devonshire House (2nd floor), 164-168 Westminster Bridge Road, London, SE1 7RW VAT Number 563105858